Early phase combined therapeutic management of acute ischaemic stroke View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-05

AUTHORS

P. Bassi, P. Lattuada, S. Tonietti

ABSTRACT

An adequate treatment of ischaemic stroke in the early phase (28–48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment. More... »

PAGES

s29-s30

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1

DOI

http://dx.doi.org/10.1007/s10072-005-0400-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011754363

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15883687


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Ischemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Emergency Treatment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibrinolytic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rehabilitation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombolytic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Plasminogen Activator", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414126.4", 
          "name": [
            "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bassi", 
        "givenName": "P.", 
        "id": "sg:person.01244141046.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244141046.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414126.4", 
          "name": [
            "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lattuada", 
        "givenName": "P.", 
        "id": "sg:person.01023024636.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023024636.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414126.4", 
          "name": [
            "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tonietti", 
        "givenName": "S.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2005-05", 
    "datePublishedReg": "2005-05-01", 
    "description": "An adequate treatment of ischaemic stroke in the early phase (28\u201348 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10072-005-0400-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294956", 
        "issn": [
          "1590-1874", 
          "1126-5442"
        ], 
        "name": "Neurological Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "ischemic stroke", 
      "accurate psychological assessment", 
      "acute ischemic stroke", 
      "treatment of hypertension", 
      "early phase", 
      "oral ASA", 
      "pharmacological therapy", 
      "cardiac disturbances", 
      "therapeutic management", 
      "effective multidisciplinary", 
      "better outcomes", 
      "adequate treatment", 
      "early detection", 
      "stroke", 
      "rehabilitation procedures", 
      "psychological assessment", 
      "outcomes", 
      "treatment", 
      "thrombolysis", 
      "hypertension", 
      "seizures", 
      "therapy", 
      "rtPA", 
      "continuous monitoring", 
      "hypertermia", 
      "days", 
      "ASA", 
      "important factor", 
      "multidisciplinary", 
      "hyperglicaemia", 
      "managment", 
      "assessment", 
      "management", 
      "factors", 
      "disturbances", 
      "procedure", 
      "precocity", 
      "monitoring", 
      "detection", 
      "phase", 
      "components", 
      "parameters", 
      "first therapeutic misures", 
      "therapeutic misures", 
      "misures", 
      "haemodinamic parameters", 
      "low haematic oxigenation", 
      "haematic oxigenation", 
      "oxigenation"
    ], 
    "name": "Early phase combined therapeutic management of acute ischaemic stroke", 
    "pagination": "s29-s30", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011754363"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10072-005-0400-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15883687"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10072-005-0400-1", 
      "https://app.dimensions.ai/details/publication/pub.1011754363"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_411.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10072-005-0400-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      21 PREDICATES      86 URIs      78 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10072-005-0400-1 schema:about N1f7b2fb8730143c1ac743e155ade9a63
2 N72ed85ea89f0449c821ef7d1fb3b6326
3 N7de51a014a00477596309cb023cc4632
4 Na69c32afb0f548eb90912597a3370ff2
5 Naa4e098a4c4a4705841cb23e2b936163
6 Nbca6d6ab1d1942b0b97d9a889ccaf995
7 Nd1121434d2d2458f957c8a6d99dde480
8 Nd169043e8f554120add89fc9f3d6acec
9 Nfcab673881fe4d43b8b126606894ecf7
10 Nfebe82ce6d0d4c04a94c1c9276743c69
11 anzsrc-for:11
12 anzsrc-for:1109
13 schema:author N5e28cd4c02994766b93d4274f6a50b17
14 schema:datePublished 2005-05
15 schema:datePublishedReg 2005-05-01
16 schema:description An adequate treatment of ischaemic stroke in the early phase (28–48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.
17 schema:genre article
18 schema:inLanguage en
19 schema:isAccessibleForFree false
20 schema:isPartOf N63a9b63f9524436094fa89d87176cb4c
21 Ne1d565b06510443e9e49196d7a1b944a
22 sg:journal.1294956
23 schema:keywords ASA
24 accurate psychological assessment
25 acute ischemic stroke
26 adequate treatment
27 assessment
28 better outcomes
29 cardiac disturbances
30 components
31 continuous monitoring
32 days
33 detection
34 disturbances
35 early detection
36 early phase
37 effective multidisciplinary
38 factors
39 first therapeutic misures
40 haematic oxigenation
41 haemodinamic parameters
42 hyperglicaemia
43 hypertension
44 hypertermia
45 important factor
46 ischemic stroke
47 low haematic oxigenation
48 management
49 managment
50 misures
51 monitoring
52 multidisciplinary
53 oral ASA
54 outcomes
55 oxigenation
56 parameters
57 pharmacological therapy
58 phase
59 precocity
60 procedure
61 psychological assessment
62 rehabilitation procedures
63 rtPA
64 seizures
65 stroke
66 therapeutic management
67 therapeutic misures
68 therapy
69 thrombolysis
70 treatment
71 treatment of hypertension
72 schema:name Early phase combined therapeutic management of acute ischaemic stroke
73 schema:pagination s29-s30
74 schema:productId N187ed95a465941e8bf8ea017e8069955
75 Nc391fbb7d2f74b9d8c27d55260689cac
76 Nff73dc30a1cc4f1386156f6767daa712
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011754363
78 https://doi.org/10.1007/s10072-005-0400-1
79 schema:sdDatePublished 2022-01-01T18:14
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher N59ee34aa4c4c44dbaa1cff2dd1406433
82 schema:url https://doi.org/10.1007/s10072-005-0400-1
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N101188d8b9d94d49bb8594a97ed777a9 schema:affiliation grid-institutes:grid.414126.4
87 schema:familyName Tonietti
88 schema:givenName S.
89 rdf:type schema:Person
90 N13724ec6cf284c20bdb6cd9f6df73d32 rdf:first N101188d8b9d94d49bb8594a97ed777a9
91 rdf:rest rdf:nil
92 N187ed95a465941e8bf8ea017e8069955 schema:name dimensions_id
93 schema:value pub.1011754363
94 rdf:type schema:PropertyValue
95 N1f7b2fb8730143c1ac743e155ade9a63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Tissue Plasminogen Activator
97 rdf:type schema:DefinedTerm
98 N59ee34aa4c4c44dbaa1cff2dd1406433 schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 N5e28cd4c02994766b93d4274f6a50b17 rdf:first sg:person.01244141046.09
101 rdf:rest N91e66f59273148dc9a011a7dda984378
102 N63a9b63f9524436094fa89d87176cb4c schema:issueNumber Suppl 1
103 rdf:type schema:PublicationIssue
104 N72ed85ea89f0449c821ef7d1fb3b6326 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Fibrinolytic Agents
106 rdf:type schema:DefinedTerm
107 N7de51a014a00477596309cb023cc4632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Emergency Treatment
109 rdf:type schema:DefinedTerm
110 N91e66f59273148dc9a011a7dda984378 rdf:first sg:person.01023024636.24
111 rdf:rest N13724ec6cf284c20bdb6cd9f6df73d32
112 Na69c32afb0f548eb90912597a3370ff2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Thrombolytic Therapy
114 rdf:type schema:DefinedTerm
115 Naa4e098a4c4a4705841cb23e2b936163 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Brain Ischemia
117 rdf:type schema:DefinedTerm
118 Nbca6d6ab1d1942b0b97d9a889ccaf995 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Acute Disease
120 rdf:type schema:DefinedTerm
121 Nc391fbb7d2f74b9d8c27d55260689cac schema:name doi
122 schema:value 10.1007/s10072-005-0400-1
123 rdf:type schema:PropertyValue
124 Nd1121434d2d2458f957c8a6d99dde480 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Rehabilitation
126 rdf:type schema:DefinedTerm
127 Nd169043e8f554120add89fc9f3d6acec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 Ne1d565b06510443e9e49196d7a1b944a schema:volumeNumber 26
131 rdf:type schema:PublicationVolume
132 Nfcab673881fe4d43b8b126606894ecf7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Time Factors
134 rdf:type schema:DefinedTerm
135 Nfebe82ce6d0d4c04a94c1c9276743c69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Humans
137 rdf:type schema:DefinedTerm
138 Nff73dc30a1cc4f1386156f6767daa712 schema:name pubmed_id
139 schema:value 15883687
140 rdf:type schema:PropertyValue
141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
142 schema:name Medical and Health Sciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
145 schema:name Neurosciences
146 rdf:type schema:DefinedTerm
147 sg:journal.1294956 schema:issn 1126-5442
148 1590-1874
149 schema:name Neurological Sciences
150 schema:publisher Springer Nature
151 rdf:type schema:Periodical
152 sg:person.01023024636.24 schema:affiliation grid-institutes:grid.414126.4
153 schema:familyName Lattuada
154 schema:givenName P.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023024636.24
156 rdf:type schema:Person
157 sg:person.01244141046.09 schema:affiliation grid-institutes:grid.414126.4
158 schema:familyName Bassi
159 schema:givenName P.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244141046.09
161 rdf:type schema:Person
162 grid-institutes:grid.414126.4 schema:alternateName Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy
163 schema:name Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...